The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.50
Bid: 1,748.50
Ask: 1,749.00
Change: 15.00 (0.87%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,750.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 22nd Oct 2014 09:54

Amino Technologies: N+1 Singer moves target price from 93p to 107p upgrading to buy.Anglo American: Liberum Capital reduces target price from 1300p to 1200p retaining its sell recommendation.ARM Holdings: UBS moves target price from 970p to 980p upgrading from neutral to buy. Deutsche Bank cuts target price from 950p to 900p and retains a hold recommendation.Ashmore Group: Liberum Capital upgrades to hold with a target price of 285p.ASOS: Liberum Capital cuts target price from 1440p to 1400p maintaining its sell recommendation.BP: Credit Suisse lowers target price from 505p to 470p staying with its neutral rating.Countrywide: Panmure Gordon reduces target price from 700p to 565p keeping a buy recommendation.Darty: Societe Generale cuts target price from 124p to 97.5p, while leaving its buy recommendation unchanged.Ferrexpo: Liberum Capital downgrades to sell.GKN: Canaccord Genuity cuts target price from 500p to 450p and reiterates a buy recommendation. Barclays cuts target price from 440p to 390p and keeps an overweight rating.GlaxoSmithKline: Panmure Gordon reduces target price from 1600p to 1425p staying with its hold recommendation.International Personal Finance: Panmure Gordon raises target price from 400p to 540p and upgrades from sell to buy.Kingfisher: Deutsche Bank lowers target price from 415p to 400p and keeps a buy recommendation.Playtech: Numis ups target price from 665p to 720p and reiterates a hold recommendation.Reckitt Benckiser: Numis cuts target price from 5600p to 5548p, while upgrading from hold to add.Royal Dutch Shell: Credit Suisse reduces target price from 2700p to 2625p and keeps an outperform rating.Senior: Numis downgrades from buy to add with a target price of 315p.Shire: Deutsche Bank raises target price from 4350p to 4550p and maintains a buy recommendation.Shoe Zone: Numis ups target price from 215p to 250p keeping a buy recommendation.Spirit Pub: Panmure Gordon downgrades from buy to hold with a target price of 110p. Shore downgrades from buy to hold.StratMin Global Resources: Northland lowers target price from 19.6p to 19.3p, while upgrading from hold to buy.Super Group: Investec reduces target price from 1500p to 1420p maintaining a buy recommendation.Travis Perkins: Liberum Capital cuts target price from 2100p to 2050p and retains a buy recommendation.Unite Group: JP Morgan ups target price from 475p to 495p and maintains an overweight rating.
More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.